Andreas Gewies Helmholtz Zentrum Munich

Home

Archive

About Us

Overview
Published
Edited
Reviewed
Following
Feedback
Q&A

Daniel Krappmann Molecular Targets and Therapies Center (MTTC) Munich
2 protocols

Thomas O'Neill Helmholtz Zentrum Munich
1 protocol

Andreas Gewies

Research Associate, Helmholtz Zentrum Munich

Research focus

Signaltransduction from antigen receptors to the transcription factor NF-kappaB

1 Author merit
Reviewer merit
Editor merit

Education

University, TU Berlin, 1996

Lab information

Daniel Krappmann's Lab
https://www.helmholtz-munich.de/azs/index.html

1 Protocol published

Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline Transmission

Authors: Thomas J. O'Neill, Daniel Krappmann and Andreas Gewies, date: 05/20/2022, view: 817, Q&A: 0

Although CRISPR-Cas9 genome editing can be performed directly in single-cell mouse zygotes, the targeting efficiency for more complex modifications such as the insertion of two loxP sites, multiple mutations in cis, or the precise insertion or

...

More >